ADVFN Logo
Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
Otonomy Inc

Otonomy Inc (OTIC)

0.077
0.00
(0.00%)
Closed November 24 4:00PM
0.00
0.00
(0.00%)

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
0.077
Bid
0.0757
Ask
0.0777
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Previous Close
0.077
Open
-
Last Trade
Last Trade Time
Average Volume (3m)
-
Financial Volume
-
VWAP
-

OTIC Latest News

Otonomy Announces Change in Stock Exchange Listing

SAN DIEGO, Dec. 22, 2022 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq: OTIC) today announced that it received a letter from the Listing Qualifications Staff of The Nasdaq Stock Market LLC (Nasdaq...

Otonomy Provides Corporate Update

SAN DIEGO, Dec. 19, 2022 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq: OTIC) today announced that the company’s board of directors, after considering strategic options, has approved and adopted a...

Otonomy Reports Third Quarter 2022 Financial Results and Provides Corporate Update

SAN DIEGO, Nov. 10, 2022 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today reported...

Otonomy Reports Results from Clinical Evaluation of OTO-413 Higher Doses in Patients with Hearing Loss

Higher dose cohorts for OTO-413 demonstrated no clinically meaningful improvement for patients from baselineLack of activity compared to 0.3 mg dose evaluated in prior studies may be due to a...

Otonomy Reports Results from Phase 2 Clinical Trial of OTO-313 in Patients with Tinnitus

OTO-313 demonstrated no clinically meaningful improvement versus placebo for primary and secondary endpoints across all timepointsCompany to discontinue development of OTO-313 and implement other...

Otonomy Reports Second Quarter 2022 Financial Results and Provides Corporate Update

Top-line results for OTO-313 Phase 2 trial in tinnitus expected in August 2022; patient enrollment completed for clinical safety evaluation of higher and bilateral dosing of OTO-313 with top-line...

Otonomy to Report Second Quarter 2022 Financial Results and Provide Corporate Update

SAN DIEGO, July 18, 2022 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today announced it...

Otonomy to Participate in the H.C. Wainwright Global Investment Conference

SAN DIEGO, May 18, 2022 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today announced its...

Otonomy Announces OTO-825 Presentation at the American Society of Gene & Cell Therapy Annual Meeting

SAN DIEGO, May 12, 2022 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today announced the...

Otonomy Reports First Quarter 2022 Financial Results and Provides Corporate Update

Positive top-line results announced for OTO-413 Phase 2a in hearing loss; enrollment ongoing for higher dose evaluationOTO-313 Phase 2 trial in tinnitus fully enrolled with top-line results...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
PDYNPalladyne AI Corporation
$ 4.59
(129.50%)
83.07M
QMCOQuantum Corporation
$ 9.11
(126.62%)
39.48M
NANano Labs Ltd
$ 8.26
(89.02%)
2.03M
XCURExicure Inc
$ 18.60
(71.27%)
4.59M
SKKSKK Holdings Limited
$ 1.75
(59.09%)
107.47M
AMIXAutonomix Medical Inc
$ 6.21
(-54.07%)
946.09k
CETXCemtrex Inc
$ 0.1146
(-41.74%)
24.39M
MSWMing Shing Group Holdings Ltd
 5.90
(-35.52%)
417.08k
RMSGReal Messenger Corporation
$ 3.09
(-26.25%)
313.51k
ENSCEnsysce Biosciences Inc
$ 0.4414
(-25.49%)
4M
ELABElevai Labs Inc
$ 0.0201
(-0.50%)
425.38M
NVDANVIDIA Corporation
$ 141.95
(-3.22%)
236.51M
SMCISuper Micro Computer Inc
$ 33.15
(11.62%)
159.61M
VRPXVirpax Pharmaceuticals Inc
$ 0.5501
(-6.72%)
159.39M
SOUNSoundHound AI Inc
$ 8.24
(18.05%)
107.91M

Discussion

View Full Feed
JOoa0ky JOoa0ky 2 minutes ago
Apparently I'm Bob Corker.
FNMA
OnTrack444 OnTrack444 3 minutes ago
You must not have much OTC experience....  if you're jumping a bid by a 10th of a cent and the spread is 5-7 cents you're not chasing a damn thing!  😂   Peace ✌️ 
AZRH
researcher59 researcher59 3 minutes ago
Schwab - all brokers accept placement of DAY and GTC orders at any time including weekends, but they are only in effect for execution during the relevant trading hours.

I was successfully able to place an EXTO order for SPY but not for TSLA.
TSLA
GetSeriousOK GetSeriousOK 4 minutes ago
That link will change, I'm sure, because at least four of us notified the VA, including you, sounds like. There's NO WAY the Contracting Officer will let that stand. The CO replied to my query promptly and he was alarmed about this listing.

Can I "prove the listing wasn't in error?"
BIEL
CanItBThisEZ2Make CanItBThisEZ2Make 5 minutes ago
BEST SELLERS RANK (BSR) IS 348 47 Estimated Sold on Amazon Since OCT 1 - 4TH Quarter 2024
https://investorshub.advfn.com/uimage/uploads/2024/4/24/cnxttVOS_5G_GIF.gif
https://www.amazon.com/Vos-RDGL5GX55-B-01-VOS-5G-Dongle/dp/B0C66KHZLP

NOTE: In theory, when BSR Value Dec
SRMX
ddls ddls 6 minutes ago
Yes according to beach this should be 25 cents by summer and raking in 5 to 10 million in sales in 2025.😈
BIEL
trader_ron trader_ron 6 minutes ago
$AIMD - PODCAST
Healthcare revolution through AI Evolution
style="caret-color: rgb(0, 0, 0); color: rgba(0, 0, 0, 1); font-family: UICTFontTextStyleBody; font-size: 17px" dir="ltr"https://drive.google.com/file/d/1QZCY2SUUD0e7vBbdZMx3CioQynqqCJvu/view?usp=drivesdk
AIMD
trader_ron trader_ron 7 minutes ago
$AIMD - PODCAST
Healthcare revolution through AI Evolution
style="caret-color: rgb(0, 0, 0); color: rgba(0, 0, 0, 1); font-family: UICTFontTextStyleBody; font-size: 17px" dir="ltr"https://drive.google.com/file/d/1QZCY2SUUD0e7vBbdZMx3CioQynqqCJvu/view?usp=drivesdk
AIMD
Hope/Misery Hope/Misery 7 minutes ago
I wonder if Merck would be interested in purchasing Halozyme thus locking up the portfolio of patents for the next so many years and be able to go ahead with the Keytruda sub q with the Korean company. They are looking at losing market share over the next 3 to 5 years if they can't get to market w
HALO
droopyeyes droopyeyes 8 minutes ago
You don't own shares so stfu
Your just a troll retard


imo 
RDAR
navycmdr navycmdr 8 minutes ago
I pay for ZERO Subscriptions - ya just need to learn how to get
around the anoying lock for pay subscription ... (here ya go) :-)
*************************&#x
FMCC UBS
HoldEm777 HoldEm777 10 minutes ago
I kinda feel obligated to be here and see this through to the end turning over every stone. Hope they run a tight ship. $RDAR
RDAR
pete807 pete807 10 minutes ago
Heck with the Wall. We need to cut the budget.
Just set these up: (Courtesy Babylon Bee)
https://babylonbee.com/news/tom-homan-introduces-family-size-immigrant-trebuchet-to-speed-up-deportation-process
capgain capgain 11 minutes ago
Thanks, the game was a total bummer, but I'm used to it. Been a lifelong fan.

Yep, Tom is the man for the job. IMO.

HAGO.
nunya54 nunya54 11 minutes ago
This is what the google AI said about the merger. Hope we get a filing soon.

Altair International Corp. (Altair) and Premier Air Charter, Inc. (Premier) finalized their merger on November 18, 2024. The merger is expected to help Altair grow in the aviation industry by increasing the n
ATAO
IH Admin [Shelly] IH Admin [Shelly] 12 minutes ago
That is a feel good story!

"Growers in the Tar Heel State produce nearly a quarter of the real Christmas trees grown in the U.S. every year," I had no idea.
HoldEm777 HoldEm777 12 minutes ago
I agree. Bashing for shares is weak. I’m not concerned with your personal opinion of me. $RDAR nothing material has changed has it? Or am I missing something?
RDAR
king_kong king_kong 13 minutes ago
100% tech company is better 
EEGI
williamssc williamssc 13 minutes ago
You have no shame. Your first post here says it all.
AVXL
M1Maggot M1Maggot 14 minutes ago
those updates are as useful as boobs on a bull....every time one comes out, the stock drops.....maybe that might be because all they keep on saying is the worn out phrase " we hope to" and the can gets kicked down this " long and winding road"
CBRF
biotechinvestor1 biotechinvestor1 14 minutes ago
Merck had no problems mivung forward because they are not at risk. It is Alteogen who has infringed Halozyme's patents. Merck has nothing to lose. They will pay alteogen and not care who alteogen has to pay for licensing or penalties.
HALO
Gman3343 Gman3343 14 minutes ago
I much rather have a tech company come into eegi , rather than a music company.
Fingers crossed we get some news soon.
Just get current.
EEGI
boston127 boston127 17 minutes ago
Thank you. Why is it that LGHL's

value is "minus $28" per share? Why is the pps only .19? Why are they being threatened with delisting from the NAZ, and cannot keep the pps above $1/share if they are earning $4/share? Why did they need to sell more shares recently? I'm not saying tha
LGHL
biotechinvestor1 biotechinvestor1 18 minutes ago
It won't be halozyme vs. Merck. It's halozyme vs. Alteogen.

Merck will be paying Alteogen a royalty for Keytruda SC. MERCK will not care if Alteogen will have to pay Halozyme a licensing fee or penalties.

If you think Merck would get invovled then by the same rational s
HALO

Your Recent History

Delayed Upgrade Clock